logo
Plus   Neg
Share
Email

Hikma Pharma Gets Rights To Commercialise 11 Of Chiesi's Products In Egypt

Hikma Pharmaceuticals PLC (HIK.L) has reached an exclusive licensing and distribution agreement with Chiesi Farmaceutici, which provides Hikma with exclusive rights to commercialise 11 of Chiesi's products in Egypt. These specialty products are primarily in respiratory and neonatal therapeutic areas.

Hikma Pharma said the new agreement, which builds on the company's existing partnership with Chiesi in Morocco, adds a range of products to the Egyptian portfolio, including Foster, Foster Nexthaler, Trimbow and Curosurf.

Chiesi Farmaceutici is a research-focused international pharmaceutical Group, headquartered in Italy.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of Deutsche Telekom AG were gaining around 4 percent in the morning trading after the German telecom giant reported Wednesday a profit in its fourth quarter, compared to last year's loss. The company also projects higher results in fiscal 2020. For the new year, Deutsche Telekom expects another increase in revenue from fiscal 2019 revenue of 80.5 billion euros. Boeing Co., which is struggling to relaunch its grounded 737 MAX jets to service, has been hit with a new potential safety concern. The planemaker found debris in the fuel tanks of several undelivered 737 MAX jetliners, multiple reports said citing an internal memo. The Foreign Object Debris were found during maintenance work on an undisclosed number of jets parked at various facilities. Tesla has been ordered to stop work at the site of its proposed $4-billion Gigafactory in the German state of Brandenburg due to environmental concerns, according to reports. The proposed factory was going to be Tesla's first Gigafactory in Europe and its fourth in the world. On Saturday, a German court reportedly ordered the company to stop cutting down trees on the 300-hectare site.
RELATED NEWS
Follow RTT
>